Monitoring patients with inflammatory bowel diseases in Emilia-Romagna

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to enhance understanding of inflammatory bowel diseases (IBD) by identifying predictive factors for aggressive disease progression, frailty, surgical needs, and post-surgical outcomes. It will also assess drug safety and quality of life related to medications and surgery. Data will be collected over a 10-year period using electronic Case Report Forms, with analyses conducted using descriptive statistics and multivariate models to evaluate risk factors and event incidences.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Signed informed consent
* Age \> 14 years
* Diagnosis of inflammatory bowel disease (Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis, Microscopic Colitis) according to ECCO guidelines
* Having undergone at least one outpatient visit and/or hospitalization at the Regional Reference Center for IBD "Massimo Campieri"
* Acquisition of written informed consent from the patient and/or both parents/legal guardian

Exclusion Criteria:

\- None

Where it's running

• IRCCS Azienda Ospedaliero-Universitaria di Bologna
  Bologna, Italy Recruiting

Study contacts

• Principal investigator: Fernando Rizzello, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
• Study coordinator: Fernando Rizzello, MD
• Email: fernando.rizzello@unibo.it
• Phone: +39 0512145312

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Maternal and infant microbiome links to infant gut inflammation and pregnancy outcomes in people with IBD

  This project will see if mothers' microbiomes, diets, and breastmilk are linked to infant gut inflammation (measured by fecal calprotectin) in pregnant people with and without IBD.

  Recruiting University of British Columbia · Vancouver, British Columbia and 1 other locations · NCT07385807

• Infliximab plus the Crohn's Disease Exclusion Diet for children with Crohn's disease

  This will test whether starting a Crohn's Disease Exclusion Diet at the same time as infliximab helps children with moderate-to-severe Crohn's disease get better and stay in remission.

  Recruiting University of British Columbia · Vancouver, British Columbia · NCT07314606

• SMART-IBD app for teens with inflammatory bowel disease

  This will test whether the SMART-IBD smartphone app helps adolescents ages 13–17 with IBD take their medicines and manage symptoms better than completing daily diaries alone.

  Recruiting Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio · NCT07195123

• Melatonin to improve sleep quality in adults with inflammatory bowel disease in remission

  This study tests whether melatonin can improve sleep quality in adults with IBD who are in clinical remission.

  Recruiting Phase 4 Mahidol University · Bangkok Noi, Bangkok · NCT07737665

• Individualizing Anti-TNF Therapy in IBD

  This study tests whether genetic markers can predict which anti-TNF–naïve IBD patients will respond to their first anti-TNF treatment.

  Recruiting Tel-Aviv Sourasky Medical Center · Tel Aviv · NCT07644117

• BDHK-2009 safety test in healthy adults

  This early-stage test checks if BDHK-2009 tablets are safe and tolerable in healthy adults aged 18–55 compared with placebo.

  Recruiting Phase 1 Benethera (Shaoxing) Biotechnology Co., Ltd. · Hangzhou, Zhejiang · NCT07632573

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.